International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Jens Hillengaß(Roswell Park Comprehensive Cancer Center), Suzanne Lentzsch(Columbia University Irving Medical Center), Dominik Dytfeld, Hermann Einsele(Universitätsklinikum Würzburg), Juan José Lahuerta(Research Institute Hospital 12 de Octubre), Jesús F. San Miguel(Clinica Universidad de Navarra), Cristina João(Universidade Nova de Lisboa), Robert A. Kyle(Mayo Clinic), Sagar Lonial(Emory University), Brian G.M. Durie(Cedars-Sinai Medical Center), Shaji Kumar(Mayo Clinic), Heinz Ludwig(Wilhelminen Hospital), María‐Victoria Mateos(Hospital Clínico San Carlos), Kenneth C. Anderson(Dana-Farber Cancer Institute), Niels W.C.J. van de Donk(Oncode Institute), Evangelos Terpos(National and Kapodistrian University of Athens), Jesús G. Berdeja(Tennessee Oncology), Noopur Raje(Massachusetts General Hospital), Rik Schots(Universitair Ziekenhuis Brussel), Elena Zamagni(Istituti di Ricovero e Cura a Carattere Scientifico), Hartmut Goldschmidt(Heidelberg University), Juan Du(Shanghai Jiao Tong University), Ramón García‐Sánz(Centro de Investigación del Cáncer), Niels Abildgaard(University of Southern Denmark), Baldeep Wirk(Boston University), S. Vincent Rajkumar(WinnMed), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Michèle Cavo(Unknown), Matthew T. Drake(Hospital for Special Surgery), Fredrik Schjesvold(Oslo University Hospital), Eloísa Riva(Hospital de Clínicas), Brea Lipe(University of Rochester), Enrique M. Ocio(Universidad de Salamanca), Wen-Ming Chen(Central South University), Saad Z. Usmani(Memorial Sloan Kettering Cancer Center)
Cited by 493
Related Papers
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k